dc.contributor.author | Keren, M. | |
dc.contributor.author | Colakoglu, B. | |
dc.contributor.author | Ciftaslan, N. | |
dc.contributor.author | Agca, M. | |
dc.contributor.author | Tepetam, F. M. | |
dc.date.accessioned | 2021-03-04T14:30:32Z | |
dc.date.available | 2021-03-04T14:30:32Z | |
dc.identifier.citation | Tepetam F. M. , Colakoglu B., Keren M., Ciftaslan N., Agca M., "Which asthma phenotype have poor response to omalizumab treatment", Congress of the European-Academy-of-Allergy-and-Clinical-Immunology, Barcelona, İspanya, 6 - 10 Haziran 2015, cilt.70, ss.349 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_81f6c9ab-903d-4bcf-92af-7d596a5f3637 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/88526 | |
dc.language.iso | eng | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | İmmünoloji | |
dc.subject | Klinik Tıp | |
dc.subject | ALERJİ | |
dc.title | Which asthma phenotype have poor response to omalizumab treatment | |
dc.type | Bildiri | |
dc.contributor.department | Istanbul Sureyyapasa Chest Diseases & Thoracic Surgery Training & Research Hospital , , | |
dc.identifier.volume | 70 | |
dc.contributor.firstauthorID | 147591 | |